Cytoo

21 articles about Cytoo

• 

  Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals

  4/6/2022

  Evozyne inked a partnership with Takeda Pharmaceutical to develop next-generation gene therapies for up to four rare disease targets. Continue reading for that and more collaboration news from this week.

• CYTOO’s Partner Astellas Gene Therapies to Present Results of an AGT/CYTOO Collaboration on Clinical Candidate Selection to Treat DMD at the 2nd Gene Therapy for Muscular Disorders Summit

  4/5/2022

  CYTOO and Astellas Gene Therapies entered into a research collaboration in 2020 to select AGT’s AAV gene therapy clinical candidate to treat Duchenne Muscular Dystrophy.

• CYTOO enters into Research and Option Agreement with Pfizer to develop a target discovery platform for Duchenne Muscular Dystrophy

  9/6/2018

• LYONBIOPOLE Will Unite Leading French Biotech Actors at the 2018 BIO International Convention

  5/31/2018

  Lyonbiopole the French "bio-cluster" based in the Auvergne-Rhône-Alpes region, will unite 35 innovative organizations at the 2018 edition of the BIO International Convention.

• Cytoo's 2D+/3D Cell Culture Platform In The Spotlight With Manuel Thery Presenting At The ASCB 2013 Annual Meeting

  12/9/2013

• Cytoo's 2D+ and 3D+ Cell Culture Platform at MipTec 2013 (Sept 24-26, Switzerland)

  9/24/2013

• Marc Le Bozec Joins Cytoo as CEO

  5/24/2013

• Olivier Pasquier Joins Cytoo as Chief Commercial Officer

  3/18/2013

• Cytoo's Adhesive Micropatterns are Mentioned in More Than 30 Scientific Papers

  3/12/2013

• Cytoo Sponsors the Motility Subgroup at the Biophysical Society Meeting

  1/28/2013

• Cytoo's 2D+ Technology and Institut Curie's Organelle Map in the Limelight at SLAS 2013 (Jan 12-16, Orlando)

  1/7/2013

• Cytoo Launches 2D+ Solutions at High Content Analysis (HCA), January 08 - 11, 2013

  1/2/2013

• Cytoo's Motility Product Launch - Exclusive Offer at American Society for Cell Biology, December 15 -19, 2012

  12/10/2012

• Cytoo's Motility Plates to Study Cell Migration to be Launched at American Society for Cell Biology, December 15-19, 2012

  12/3/2012

• Cytoo's 2D + Cell Culture Platform Reproduces in Vivo Conditions to Study Tumor Cell Motility

  10/17/2012

• Cytoo's 2D+ Cell Culture Platform Enables Quantitative Mapping of Trafficking Compartments and Standardized Mitochondrial Analysis

  9/18/2012

• Cytoo, Cenix BioScience GmbH and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 Million€ EU FP7 Grant to Launch MEHTRICS Consortium

  12/12/2011

• Cytoo Raises $10 Million in Series C Round

  11/23/2011

• Cytoo is Official Sponsor of the First Edition of the World Cell Race

  5/24/2011

• CYTOO SA: ReferenceCell Platform for Improved High Content Screening will be Assessed by Leading Industry Consortium

  4/27/2011